… , mixed chimerism levels may affect the event free survival (… the first 100-day donor chimerism
ratios and to search for a … within the first 100 days was the most important predictor of EFS. …

… -free survival (EFS) was defined as time from HCT to relapse, … strongest predictor for a better
outcome was a donor chimerism … by whole bone marrow donor chimerism 2–4 weeks post-…

… relapsed (all patients had acute myeloid leukemia). Of the 21 … the Nagoya Blood and Marrow
Transplantation Group Study … of relapse, we considered whether falling donor chimerism …

… , and 1 in chronic myeloid leukemia myeloid blast crisis were … immunotherapy with HLA
haploidentical donor cells, has … Survival and progression-free survival were calculated using the …

… disorders for which a bone marrow transplant was done. … a case of Acute Myeloid
Leukaemia (AML). Two haploidentical … donor chimerism with relapse in a patient of AML (1b). …

… high-risk myeloid leukaemias tend to relapse within the first 6… , and act as a surrogate indicator
of red cell engraftment. Red … leukaemic patients post HSCT, a drop in donor chimaerism is …

… from mixed to full donor chimerism after DLIs for PMC or relapse is a gradual … chimerism for
monitoring chronic myeloid leukemia patients treated by DLI for post-transplant relapse 34, 35…

… Chimerism analysis following hematopoietic stem cell … refers to the presence of hematopoietic
cells of donor origin after … included patients transplanted for chronic myeloid leukemia (…

… ), 2 of 3 with chronic myeloid leukemia (CML; 2 molecular CR… event-free survival when
compared to a haplotype AA donor (… following autologous bone marrow transplantation. Exp …

… progression in the MAC but not in MAC-DLI group. The only factor favorably influencing
disease progression and progression-free survival … Donor chimerism at day 30 was > 95% in all …